//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~language:"und"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: person:"Langreth, Robert"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Type of publication
All
Article
126
Language
All
Undetermined
Author
All
Langreth, Robert
126
Herper, Matthew
18
Kellner, Tomas
2
Helman, Christopher
1
Herper, Mathew
1
Herper, Matt
1
Lambert, Emily
1
Moukheiber, Zina
1
Murphy, Victoria
1
Noer, Michael
1
Ruiz, Rebecca
1
Whelan, David
1
Williams, Elisa
1
more ...
less ...
Published in...
All
Forbes : business and finance
125
Le nouvel économiste : journal d'analyse & d'opinion paraissant le vendredi
1
Source
All
OLC EcoSci
126
Showing
1
-
10
of
126
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
SHRINK IT, CURE IT GlaxoSmithKline Chief Andrew Witty has a plan to save the struggling drugmaker.
Langreth, Robert
- In:
Forbes : business and finance
(
2011
),
pp. 80-84
Persistent link: https://www.econbiz.de/10008786228
Saved in:
2
DATA DRIVEN: ANTIBIOTIC ARTISAN Chemist William DeGrado crafts new drugs that mimic nature's own defenses.
Langreth, Robert
- In:
Forbes : business and finance
(
2011
),
pp. 42-46
Persistent link: https://www.econbiz.de/10008819299
Saved in:
3
HEALTH CARE - GRAND PLANS - Randal Kirk got rich in biotech. It could pale next to his latest project.
Langreth, Robert
;
Herper, Matthew
- In:
Forbes : business and finance
(
2011
),
pp. 86-89
Persistent link: https://www.econbiz.de/10008877115
Saved in:
4
Forbes - MEDICAL MIRACLE - LARS SØRENSEN MAKES NOVO NORDISK A BIOTECH STAR - The once sleepy Danish drug company made its name selling insulin for diabetes. Facing competition, Sør...
Langreth, Robert
- In:
Forbes : business and finance
(
2011
),
pp. 78-84
Persistent link: https://www.econbiz.de/10008846472
Saved in:
5
CAREERS - First Down and 60 - Being chief executive of TD Ameritrade wasn't enough; Joe Moglia tries college football.
Langreth, Robert
;
Herper, Matthew
- In:
Forbes : business and finance
(
2010
),
pp. 48-51
Persistent link: https://www.econbiz.de/10008351540
Saved in:
6
AMERICA'S BEST COMPANIES - Company of the Year: Monsanto - Monsanto's first round of attackers said its seeds were evil. Now the charge is that Monsanto's seeds are too good.
Langreth, Robert
;
Herper, Matthew
- In:
Forbes : business and finance
(
2010
),
pp. 64-70
Persistent link: https://www.econbiz.de/10008377736
Saved in:
7
HEALTH The mental health industry ignores the 35,000 people a year who commit suicide. A few researchers are trying to change that.
Langreth, Robert
;
Ruiz, Rebecca
- In:
Forbes : business and finance
(
2010
),
pp. 32-38
Persistent link: https://www.econbiz.de/10008718558
Saved in:
8
DECODING AUTISM Can it be treated with drugs? MIT researcher Mark Bear offers a glimmer of hope.
Langreth, Robert
- In:
Forbes : business and finance
(
2010
),
pp. 121-125
Persistent link: https://www.econbiz.de/10008745783
Saved in:
9
ENTREPRENEURS STANDING UP Frank Manganaro stood tough when rivals tried to sue his firm into oblivion.
Langreth, Robert
- In:
Forbes : business and finance
(
2010
),
pp. 50-56
Persistent link: https://www.econbiz.de/10008745791
Saved in:
10
NAMES WE NEED TO KNOW IN 2011 WE OPEN UP OUR PAGES TO READERS FOR YOUR PICKS What are the people, places, ideas and products everyone will be talking about next year? How about Jan...
Noer, Michael
;
Langreth, Robert
- In:
Forbes : business and finance
(
2010
),
pp. 88-130
Persistent link: https://www.econbiz.de/10008767491
Saved in:
1
2
3
4
5
6
7
8
9
10
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->